Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
复制标题
DOI：
10.2337/dc08-9025
复制
发表时间：
2009-01
期刊：
影响因子：
16.2
通讯作者：
European Association for Study of Diabetes
中科院分区：
文献类型：
--
作者：
Nathan DM;Buse JB;Davidson MB;Ferrannini E;Holman RR;Sherwin R;Zinman B;American Diabetes Association;European Association for Study of Diabetes
2型糖尿病医疗管理的共识算法于2006年8月发布，预计将根据新干预措施的可用性和确定其临床作用的新证据对其进行更新。作者继续认可用于开发算法及其主要功能的原则。我们对随意或过于频繁地改变算法的风险很敏感，因为没有引人注目的新信息。2008年1月发布的共识算法更新专门解决了围绕噻唑烷二酮类药物的安全问题。在这次修订中，我们重点介绍了现在有更多临床数据和经验的新类别药物。
The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm published in January 2008 specifically addressed safety issues surrounding the thiazolidinediones. In this revision, we focus on the new classes of medications that now have more clinical data and experience.
登录
查看更多内容
影响因子：
168.9
作者：
Dormandy, JA;Charbonnel, B;Taton, J
通讯作者：
Taton, J
影响因子：
158.5
作者：
Gerstein, Hertzel C.;Miller, Michael E.;Friedewald, William T.
通讯作者：
Friedewald, William T.
影响因子：
16.2
作者：
Damsbo, P;Clauson, P;Windfeld, K
通讯作者：
Windfeld, K
影响因子：
16.2
作者：
Gerich, J;Raskin, P;Baron, MA
通讯作者：
Baron, MA
影响因子：
120.7
作者：
Chiasson, JL;Josse, RG;Laakso, M
通讯作者：
Laakso, M